Plasma
Plasma is a biological therapy with 22 clinical trials. Currently 1 active trials ongoing. Historical success rate of 83.3%.
Success Metrics
Based on 10 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
8
Mid Stage
5
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
66.7%
10 of 15 finished
33.3%
5 ended early
1
trials recruiting
22
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Plasma Resuscitation Early for Evaluating Volume and Endotheliopathy of Thermal Injury (PREEVEnT) Trial
High-Titer Neutralizing Plasma for West Nile Fever in Hospitalized Patients
Collection of Plasma From People Who Recovered From or Were Vaccinated to Emerging Infectious Diseases
Early Use of Cryoprecipitate With Major Hemorrhage Protocol (MHP) Activation
Risk Prediction Model for Cerebrovascular Events in Carotid Artery Stenosis
Clinical Trials (22)
Plasma Resuscitation Early for Evaluating Volume and Endotheliopathy of Thermal Injury (PREEVEnT) Trial
High-Titer Neutralizing Plasma for West Nile Fever in Hospitalized Patients
Collection of Plasma From People Who Recovered From or Were Vaccinated to Emerging Infectious Diseases
Early Use of Cryoprecipitate With Major Hemorrhage Protocol (MHP) Activation
Risk Prediction Model for Cerebrovascular Events in Carotid Artery Stenosis
Observational Study to Compare Two Prostate Laser Enucleation Techniques in Terms of Urinary Incontinence
Resuscitation With Plasma in Surgical and Trauma Patients With Septic Shock
Convalescent Plasma Compared to the Best Available Therapy for the Treatment of SARS-CoV-2 Pneumonia
An Observational Cohort Study to Investigate the Risk of Thromboembolic Events in Patients Receiving Kcentra® or Plasma to Reverse Vitamin K Antagonist (VKA) Therapy in the Setting of Acute Major Bleeding
Peer Led Asthma Self Management for Adolescents: PLASMA
Convalescent Plasma for Patients With COVID-19: A Randomized, Single Blinded, Parallel, Controlled Clinical Study
Convalescent Plasma for Patients With COVID-19: A Pilot Study
Pilot Study to Compare Fresh Frozen Plasma With 24-Hour Plasma in Babies Up to Age Six Months
Characterization of Endothelial Dysfunction as a Function of Hyperaemia of the Brachial Artery During Cardiac Surgery
Young Donor Plasma Transfusion and Age-Related Biomarkers
Evaluation of the Safety of Octaplas™ Versus Plasma in Patients Undergoing Orthotopic Liver Transplantation
The PLasma for Alzheimer SymptoM Amelioration (PLASMA) Study
Evaluation of Platelet Rich Plasma (PRP) for Knee Osteoarthritis
Pre-Hospital Use of Plasma for Traumatic Hemorrhage
Plasma Transfusion in Liver Transplantation
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 22